Christopher Galletta - Controller and Principal Accounting Officer at Trevi Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Controller and Principal Accounting Officer
Stock Symbol
TRVI on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Christopher Galletta since 12/22/2023

Holdings reported by Christopher Galletta for Trevi Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 19.9K $10.2K $0.51 Dec 13, 2024 Direct
Stock Option (right to buy) 20K Dec 13, 2024 Direct Common Stock

Transactions reported by Christopher Galletta for Trevi Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.